Stay informed with the latest litigation news. Explore now

IP Verse

Teva Pharmaceuticals International Gmbh V. Bendarx Usa Corp - 1:23-cv-00788

Explore the details of the Teva Pharmaceuticals International Gmbh V. Bendarx Usa Corp case under case number 1:23-cv-00788 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00788
Filing Date
Jun 16, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Applications (ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Cephalon, LLC -
Teva Pharmaceuticals International GmbH -
BendaRx USA Corp -
Eagle Pharmaceuticals, Inc. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 12, 2023Memorandum in Support re 47 MOTION to Seal Exhibit B to Opposition to Plaintiffs' Motion to Stay filed by BendaRx USA Corp. (Bagley, Andrew) (Entered: 07/12/2023)PACER Document
Jul 12, 2023*** Motion Hearing deadline terminated - Per RDA's chambers motion set for 7/19/2023 will be decided on the papers; no oral argument will be heard (tarm)PACER Document
Jul 12, 2023Sealed Attachment/Exhibit(s) re 47 MOTION to Seal Exhibit B to Opposition to Plaintiffs' Motion to Stay. (Bagley, Andrew) (Entered: 07/12/2023)PACER Document
Jul 12, 2023NOTICE by BendaRx USA Corp re 47 MOTION to Seal Exhibit B to Opposition to Plaintiffs' Motion to Stay (Bagley, Andrew) (Entered: 07/12/2023)PACER Document
Jul 12, 2023Proposed Joint Discovery Plan by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Eckstein, Maya) (Entered: 07/12/2023)PACER Document
Jul 13, 2023NOTICE by BendaRx USA Corp re 46 Memorandum in Opposition, Corrected Exhibit H to Defendant's Opposition to Plaintiffs' Motion to Stay (Bagley, Andrew) (Entered: 07/13/2023)PACER Document
Jul 17, 2023NOTICE of Appearance by Joshua B Pond on behalf of BendaRx USA Corp (Pond, Joshua) (Entered: 07/17/2023)PACER Document
Jul 17, 2023Reply to Motion re 22 MOTION to Stay filed by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit X, # 2 Exhibit Y)(Eckstein, Maya) (Entered: 07/17/2023)PACER Document
Jul 18, 2023ORDER granting 45 Motion for Pro hac vice Appointed Ben Picozzi for Cephalon, LLC,Ben Picozzi for Teva Pharmaceuticals International GmbH. Signed by District Judge Rossie D. Alston, Jr on 7/18/2023. (swil) (Entered: 07/20/2023)PACER Document
Jul 19, 2023ORDER granting 22 Motion to Stay. ORDERED that this matter is STAYED until Final Judgment or order in each of Case Nos. 23-cv-490-CFC (D. Del) and 23-cv-633-CFC (D. Del.). Signed by District Judge Rossie D. Alston, Jr on 07/19/2023. SEE ORDER FOR FURTHER DETAILS. (wgar, ) (Entered: 07/19/2023)PACER Document
Jul 19, 2023Minute Entry for proceedings held before Magistrate Judge William E. Fitzpatrick: Initial Pretrial Conference held on 7/19/2023. Appearance of counsel. Proposed Discovery Plan discussed in open court. Shortly after the IPC, Judge Alston issued an order staying this entire case. Therefore, a Rule 16(b) order will not be issued by Judge Fitzpatrick-per WEF chambers. (Tape #FTR.)(tfitz, ) (Entered: 07/21/2023)PACER Document
Jul 21, 2023ORDERED that the parties shall contact the undersigned's chambers within 14 days of the stay being lifted, to schedule a status conference regarding the adoption of a discovery plan and the entry of a discovery order. Signed by Magistrate Judge William E. Fitzpatrick on 7/21/2023. (swil) (Entered: 07/21/2023)PACER Document
Jul 21, 2023ORDER granting 47 Motion to Seal. ORDERED that Dkt. 49 shall remain sealed; it is further ORDERED that Defendant shall submit a response to Plaintiff's Motion to Seal (Dkt. 24), complying with the requirements under Local Civil Rule 7(C), within 7 days of entry of this Order. Signed by Magistrate Judge William E. Fitzpatrick on 07/21/2023. (wgar, ) (Entered: 07/21/2023)PACER Document
Aug 2, 2023Consent MOTION for Extension of Time to File Response/Reply as to 24 MOTION to Seal Exhibits A and B to Motion to Stay by BendaRx USA Corp. (Attachments: # 1 Proposed Order)(Pond, Joshua) (Entered: 08/02/2023)PACER Document
Aug 2, 2023RESPONSE to Motion re 24 MOTION to Seal Exhibits A and B to Motion to Stay filed by BendaRx USA Corp. (Attachments: # 1 Exhibit B (Redacted), # 2 Proposed Order)(Pond, Joshua) (Entered: 08/02/2023)PACER Document
Aug 14, 2023ORDERED that the Consent Motion for Extension of Time to File a Response to Motion to Seal 60 is DISMISSED as moot; it is further ORDERED that Defendant shall file further argument in support of the Motion to Seal 24, consistent with the requirements of Local Civil Rule 5(C), within seven (7) days of entry of this Order and, if appropriate, an updated redacted version of Exhibit B; it is further ORDERED that Defendant shall file a publicly available version of Exhibit A; it is further ORDERED that Exhibit B shall remain sealed pending a determination by the Court on the Motion to Seal. Signed by Magistrate Judge William E. Fitzpatrick on 8/14/2023. (tran, ) (Entered: 08/15/2023)PACER Document
Aug 21, 2023Notice of Filing Sealing Motion LCvR5(C) by BendaRx USA Corp re 23 Memorandum in Support,, portions of Exhibit B (Pond, Joshua) (Entered: 08/21/2023)PACER Document
Aug 21, 2023MOTION to Seal by BendaRx USA Corp. (Attachments: # 1 Proposed Order)(Pond, Joshua) (Entered: 08/21/2023)PACER Document
Aug 21, 2023RESPONSE to Motion re 24 MOTION to Seal Exhibits A and B to Motion to Stay (Defendant's Supplemental Response) filed by BendaRx USA Corp. (Attachments: # 1 Exhibit A, # 2 Exhibit B (redacted))(Pond, Joshua) (Entered: 08/21/2023)PACER Document
Aug 29, 2023ORDERED that the parties' respective Motions to Seal Exhibit B to Plaintiffs' Memorandum (Dkts. 24, 64) are GRANTED and the redacted portions of Exhibit B shall remain permanently under seal; it is further ORDERED that Plaintiff's Motion to Seal Exhibit A is deemed WITHDRAWN (see Order for further details). Signed by Magistrate Judge William E. Fitzpatrick on 8/29/2023. (Dest) (Entered: 08/29/2023)PACER Document